These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 21302442

  • 1. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].
    Zhou RQ, Gong YP, Zheng BH, Yang X.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):789-92. PubMed ID: 21302442
    [Abstract] [Full Text] [Related]

  • 2. [The anti-leukemic effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with Ph(+)].
    Yang X, Yang L, Gong YP, Chang H, Zhou RQ, Xing HY, Zheng BH.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):793-6. PubMed ID: 21302443
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Study on the sensitization of acute myeloid leukemia cell to daunorubicin by recombinant human interleukin-3].
    Wang J, Wang Q, Chen X.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):30-2. PubMed ID: 11498841
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular mechanisms of converting K562/DNR cellular drug-resistance by bortezomib.
    Li YC, Wang HH, Liao AJ, Fu BB, Zhang R, Li J, Yang Y, Liu ZG, Yang W.
    Eur Rev Med Pharmacol Sci; 2014 Jan; 18(10):1465-72. PubMed ID: 24899604
    [Abstract] [Full Text] [Related]

  • 10. [Mechanism of bortezomib in inducing apoptosis and improving chemosensitivity of Ishikawa cells].
    Shen Y, Hu HY, Lu L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1301-3, 1309. PubMed ID: 20584662
    [Abstract] [Full Text] [Related]

  • 11. [Synergistic effects of proteasome inhibitor and histone deacetylase inhibitor on apoptosis and aggresome formation in T lymphoma cells].
    Jiang XX, Zhang QL, Chen XY, Wu WL, Shen ZX, Zhao WL.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1215-9. PubMed ID: 19840453
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Proliferation-inhibiting and multidrug-resistant reversing effect of bortezomib on human HL-60 cells].
    Shang J, Chen ZZ, Wu WB, Wei TN, Chen WM.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):911-6. PubMed ID: 23363746
    [Abstract] [Full Text] [Related]

  • 14. [Apoptosis in Jurkat cells induced by bortezomib combined with adriamycin].
    Chen JF, Jin J.
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):890-3. PubMed ID: 20193325
    [Abstract] [Full Text] [Related]

  • 15. [Effects of arsenic trioxide combined with bortezomib on proliferation and apoptosis of K562 cells and their mechanism].
    Wu HY, Wang SM, Huang JQ, Hao LM, Li XM, Wei LY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1361-4. PubMed ID: 23257433
    [Abstract] [Full Text] [Related]

  • 16. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C, Hassan HT.
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [Abstract] [Full Text] [Related]

  • 17. [Leukemic bone marrow stromal cells in vitro protect leukemic cell line Jurkat cells from daunorubicin-induced apoptosis].
    Li ZJ, Teng BX, Chen XH, Kong PY, Wang JG, Peng XG, Yang ZZ.
    Ai Zheng; 2005 Jun; 24(6):672-5. PubMed ID: 15946476
    [Abstract] [Full Text] [Related]

  • 18. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J, Xu DR, Zheng FM, Long ZJ, Huang SS, Wu X, Zhou WH, Huang RW, Liu Q.
    J Transl Med; 2011 May 19; 9():71. PubMed ID: 21595920
    [Abstract] [Full Text] [Related]

  • 19. [In vitro effect of bortezomib alone or in combination with harringtonine or arsenic trioxide on proliferation and apoptosis of multidrug resistant leukemia cells].
    Cai YX, Meng FY, Sun QX, Fu YB, Li L.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov 19; 29(11):737-40. PubMed ID: 19176009
    [Abstract] [Full Text] [Related]

  • 20. Effects of arsenic trioxide combined with bortezomib on apoptosis of multiple myeloma cell line KM3 and its mechanisms.
    Ge QF, Ouyang GF, Chen Y, Zhang Y, Mu QT, Lu Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb 19; 20(1):112-5. PubMed ID: 22391178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.